Evidence map›Paper›PMID 25719574›Full record

ReviewCurrent opinion in hematology2015

Human and murine erythropoiesis.

Xiuli An, Vincent P Schulz, Narla Mohandas, Patrick G Gallagher

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Dysfunction of CD169Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
  12. Post-transcriptional regulation of erythropoiesis.Blood science (Baltimore, Md.) · 2023
    Review
  13. Article
  14. Article
  15. The role of mitochondria in rheumatic diseases.Nature reviews. Rheumatology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiuli AnaLaboratory of Membrane Biology bRed Cell Physiology Laboratory, the New York Blood Center, New York, New York, USA cCollege of Life Science, Zhengzhou University, Zhengzhou, Henan, China dDepartment of Pediatrics eDepartment of Pathology and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Vincent P Schulz
Narla Mohandas
Patrick G Gallagher

Funding

RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR37DK026263 · NIDDK · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI NARLA, MOHANDAS · 1995 to 2017
$4.5M
MOLECULAR BIOLOGY OF HUMAN ERYTHROCYTE ALPHA-SPECTRINR01HL065448 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2000 to 2013
$4.4M
Regulation of Erythrocyte Volume HomeostasisR01DK104046 · NIDDK · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2014 to 2020
$2.1M
Barrier Insulators in ErythropoiesisR01HL106184 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2011 to 2014
$1.6M
RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR01DK026263 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1986 to 2007
$1.6M
TET3 in Terminal Erythroid DifferentiationR01DK100810 · NIDDK · NEW YORK BLOOD CENTER · PI AN, XIULI · 2014 to 2016
$875k
NHLBI NIH HHS HL106184NHLBI NIH HHS HL65448NHLBI NIH HHS R01 HL065448NHLBI NIH HHS R01 HL106184NIDDK NIH HHS DK100810NIDDK NIH HHS DK104046NIDDK NIH HHS DK26263NIDDK NIH HHS R01 DK026263NIDDK NIH HHS R01 DK100810NIDDK NIH HHS R01 DK104046NIDDK NIH HHS R37 DK026263
6 · The paper itself

Abstract

purpose of reviewResearch into the fundamental mechanisms of erythropoiesis has provided critical insights into inherited and acquired disorders of the erythrocyte. Studies of human erythropoiesis have primarily utilized in-vitro systems, whereas murine models have provided insights from in-vivo studies. This report reviews recent insights into human and murine erythropoiesis gained from transcriptome-based analyses. RECENT

findingsThe availability of high-throughput genomic methodologies has allowed attainment of detailed gene expression data from cells at varying developmental and differentiation stages of erythropoiesis. Transcriptome analyses of human and murine reveal both stage and species-specific similarities and differences across terminal erythroid differentiation. Erythroid-specific long noncoding RNAs exhibit poor sequence conservation between human and mouse. Genome-wide analyses of alternative splicing reveal that complex, dynamic, stage-specific programs of alternative splicing program are utilized during terminal erythroid differentiation. Transcriptome data provide a significant resource for understanding mechanisms of normal and perturbed erythropoiesis. Understanding these processes will provide innovative strategies to detect, diagnose, prevent, and treat hematologic disease. SUMMARY: Understanding the shared and different mechanisms controlling human and murine erythropoiesis will allow investigators to leverage the best model system to provide insights in normal and perturbed erythropoiesis.

Indexed as

AnimalsCell DifferentiationErythropoiesisHumansMice

Identifiers

PMID25719574
PMCPMC4401149

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.